MYELOID TARGETING PLATFORM Trademark

Trademark Overview


On Friday, July 14, 2023, a trademark application was filed for MYELOID TARGETING PLATFORM with the United States Patent and Trademark Office. The USPTO has given the MYELOID TARGETING PLATFORM trademark a serial number of 98086316. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, November 12, 2024. This trademark is owned by UNITED IMMUNITY, CO., LTD.. The MYELOID TARGETING PLATFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical research services in the field of cancer; scientific research; medical research; medical and scientific research in the field of drug discovery; pharmaceutical research services; medical and scientific research information in the field of drug discovery; DNA screening for scientific research purposes; laboratory research services relating to pharmaceuticals; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; cell culture services for scientific and research purposes, for others; providing medical and scientific research information; consulting services in the field of pharmaceutical research and development; DNA analysis services for scientific research purposes; scientific research consulting
myeloid targeting platform

General Information


Serial Number98086316
Word MarkMYELOID TARGETING PLATFORM
Filing DateFriday, July 14, 2023
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"MYELOID TARGETING"
Goods and ServicesResearch and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical research services in the field of cancer; scientific research; medical research; medical and scientific research in the field of drug discovery; pharmaceutical research services; medical and scientific research information in the field of drug discovery; DNA screening for scientific research purposes; laboratory research services relating to pharmaceuticals; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals; cell culture services for scientific and research purposes, for others; providing medical and scientific research information; consulting services in the field of pharmaceutical research and development; DNA analysis services for scientific research purposes; scientific research consulting

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 14, 2023
Primary Code042
First Use Anywhere DateMonday, June 3, 2024
First Use In Commerce DateMonday, June 3, 2024

Trademark Owner History


Party NameUNITED IMMUNITY, CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-0022
JP

Trademark Events


Event DateEvent Description
Tuesday, July 18, 2023NEW APPLICATION ENTERED
Monday, August 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 21, 2024ASSIGNED TO EXAMINER
Monday, March 25, 2024NON-FINAL ACTION WRITTEN
Monday, March 25, 2024NON-FINAL ACTION E-MAILED
Monday, March 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 24, 2024USE AMENDMENT FILED
Wednesday, October 9, 2024ASSIGNED TO LIE
Monday, June 24, 2024TEAS AMENDMENT OF USE RECEIVED
Monday, June 24, 2024AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, October 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 11, 2024USE AMENDMENT ACCEPTED
Tuesday, November 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 12, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, November 12, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, November 12, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 12, 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER